Heterogeneous Technology Alliance Template HTA General Assembly November 12 – 13, 2013.

Slides:



Advertisements
Similar presentations
[IPO0663] Study of the effects of cosmetic products to improve the condition of dry skin B.Tyszczuk 1, C. Vincent 1,R. Debowska 1, A. Kaszuba 2, A. Kaszuba.
Advertisements

Areas of Research Specific issues. Clinical Trials Phase I First use in humans of an experimental drug or treatment In a small group of healthy volunteers.
Research Within The NHS Prof Alison MacLeod Director Research & Development.
Food Standards Agency Nutrition Research Dr Andrew Wadge Chief Scientist Food Standards Agency June 2008.
Commercialization Programs Database Applications.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
EHealth Unit FP6 - 1st IST Call for Proposals 28/1/2003 The eHealth Strategic Objective Julian Ellis eHealth Unit, DG Information Society
A Smart Sensor to Detect the Falls of the Elderly.
What’s Coming? Today (Feb 11) Elevator Speech Exercise + Competition (60’)- this is graded (6%) Defining Major Milestones (20’)- Major activities that.
What Do Toxicologists Do?
Sensors and Their Uses in Hospitals
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Home Health Care and Assisted Living John Stankovic, Sang Son, Kamin Whitehouse A.Wood, Z. He, Y. Wu, T. Hnat, S. Lin, V. Srinivasan AlarmNet is a wireless.
Essentia EMR Jenifer Brilla CRNP Wilkes University.
“Put the Power of Predictive Analytics in the Hands of Clinical Researchers” Filippos Katsampouris Marketing Manager Healthcare & Pharmaceutical Accounts.
Wirelessly Accessible Sensor Populations (WASP) for Elderly Care Monitoring Presented by Student Name: Ashraf Youssef Mostafa.
2004 Falls County Health Survey Texas Behavioral Risk Factor Surveillance System (BRFSS)
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Artificial Tendon Artificial Skin Artificial Ligament Artificial Cornea Soft Tissues Implants Different Products Constitute This Sector Cosmetic Lens.
1 Safety Pharmacology for Oncology Pharmaceuticals at CDER John K. Leighton Associate Director for Pharmacology CDER/OND/OODP.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
EF on IST in FP6 in Greece Information Day Athens-Thessaloniki, December 2002 The IST Priority in FP6 Erastos Filos
Heterogeneous Technology Alliance Template HTA General Assembly November 12 – 13, 2013.
CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:
Evaluation of software engineering. Software engineering research : Research in SE aims to achieve two main goals: 1) To increase the knowledge about.
Study Designs Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
Heterogeneous Technology Alliance Template HTA General Assembly November 12 – 13, 2013.
By: Dr Alireza Kazemi.  Computer science, the study of complex systems, information and computation using applied mathematics, electrical engineering.
1 Survey of Health, Ageing and Retirement in Europe Andrzej Ryś - Director Public Health European Commission DG SANCO 28 November 2008.
Biomedical Research Objective 2 Biomedical Research Methods.
Heterogeneous Technology Alliance Template HTA General Assembly November 12 – 13, 2013.
EC Bathing Waters and Bathing Water quality management Calum McPhail Environmental Quality Unit manager Caroline Dilks Senior Scientist.
Evidence, guidelines and practice: the way forward in a digital age SYDNEY 11 April, 2013 Bill Runciman Professor – Patient Safety & Healthcare Human Factors.
MSC and the School of Healthcare Science Dr Chris Gibson National Professional Adviser for Physics and Engineering.
Heterogeneous Technology Alliance Template HTA General Assembly November 12 – 13, 2013.
IDF Europe GA Munich October 16, 2005 Italian national database on diabetes and its complications. Marco A. Comaschi – AMD - Italy.
JUNIOR RASHID SHAFEER CS 7 – 7509 YCET CONTENTS o EVOLUTION o OVERVIEW o PROMISES AND POTENTIAL o REALITY o ANALYSIS o CONCLUSION o REFERENCES.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
Health Time Smart-Skin sensing for Real-Time Lifestyle guidance.
Lung Volume Reduction Surgery and Quality of Life Amy Burker ALHE 4060/ Masini April 22, 2007.
Developing medicines for the future and why it is challenging Angela Milne.
Supporting Researchers and Institutions in Exploiting Administrative Databases for Statistical Purposes: Istat’s Strategy G. D’Angiolini, P. De Salvo,
Heterogeneous Technology Alliance SIS Facility Reloaded HTA General Assembly November 12 – 13, 2013.
Internal Fundamentals of Performance Measurement Dr. Mohammed Alahmed Dr. Mohammed Alahmed 1.
June 24, 2003 Health Communications Progress Review Focus Area 11.
BY: SAMIRA HAMOUD, ASHLEY EDWARDS & ANGELA PADILLA
IEEE N SubmissionLiang Li VinnoSlide 1 Project: IEEE P Working Group for Wireless Personal Area Networks (WPANs) Submission.
PPG APPENDIX 2. PPG MIINUTES PATIENT SURVEY 2011 PRELIMINARY FINDINGS 1.
BRIDGING THE GAP BETWEEN CLINICAL RESEARCH AND CARE Philips Research Europe Brussels, February 2012 EHR4CR WP4-Semantic Interoperability: Convergence Meeting.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Innovation Tools: Innovation Dashboard & Opportunity Assessment Templates.
WEARABLE TECHNOLOGY. OVERVIEW History Key Vendors Uses and Benefits Issues Future Uses.
ERP and Related Technologies
Major Biogeochemical Processes Visualized by Aerosols Dust storms VolcanoesAnthropogenic pollution These processes are producing visible aerosols in form.
Wearable health systems: from smart technologies to real applications Lymberis A, Gatzoulis L European Commission, Information Society and Media Directorate-
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
PACS as Medical Devices
Present: Disease Past: Exposure
Clinical Studies Continuum
Does One Size Fit All in Obesity Management?
11/20/2018 Study Types.
Milena Lonati PD Quality Management DG2, European Patent Office
College of Medicine Strategic Planning Update November 2012
Mpundu MKC MSc Epidemiology and Biostatistics, BSc Nursing, RM, RN
Objective 2 Biomedical Research Methods
P-Care Personal health CARE for monitoring Cardiovascular Disease
ARTIFICIAL INTELLIGENCE APPLICATION IN HEALTH CARE by
Novel Laser Scanning System
Presentation transcript:

Heterogeneous Technology Alliance Template HTA General Assembly November 12 – 13, 2013

The Heterogeneous Technology Alliance HTA Project Idea: Smart Vest EU call:H2020-PHC10, 16, 19 or 2 Project Idea short description: Fully automised process for the manufacture of custom-made (personalized) smart vests Short Description: Good physiological signals are obtained with well-fitted vest. However, strategic end-users usually have a large variety of body shapes due to age or obesity. Therefore, there is a need for the manufacture of personalized smart vest fitting the body shape and with an easy process for assembly of the vest with the sensors. IP situation and commercial viability: CSEM has a large patent portfolio about button-like standalone sensors for physiological signals Potential Applications / Applications: Health, Fitness and Wellness, Sports, Security, etc. Potential Consortium/Competences needed: --- CSEM for the sensors --- x for the body scan (up to a 3D torso model) --- y for the taylor (translate the 3D torso model to garment model, taking into account gravity, fabric elasticity, etc.) --- z for the knitting machine (translate garment model to seamless «printing» of vest) Contact:

The Heterogeneous Technology Alliance HTA Advertisement/Presentation of the ”end product” Good signals = well-fitted vest = personalized vest especially important for obese, elderly, etc. body scancomputer modelcomputer-controlled seamless knitting maching personalized vest with embedded button-like sensors

The Heterogeneous Technology Alliance HTA Project Idea: Universal medical model EU call:H202-PHC25, 24, 28 or 16 Project Idea short description: Use (all) patients with their real environment to develop further the UMM Short Description: Clinical trials as performed today are more and more difficult to be performed due to increasing regulation. Moreover, they do not fully take into account influences of external factors. Clinical trials of the future will be more with cell culture and with (all) real patients. The idea is to use the huge amount of data from more than 1 billion patients that will be available in the future to automatically refine the UMM (universal medical model). IP situation and commercial viability: CSEM has a large patent portfolio about the development of button-like standalone sensors for the measurement of many physiological signals Potential Applications / Applications: Health, Pharma, Medical science Potential Consortium/Competences needed: --- CSEM for continuous wearable monitoring --- x for data minining, data reduction (incl. modelling) --- many, many others (still unclear, concept to develop by computer scientists) Contact:

The Heterogeneous Technology Alliance HTA Advertisement/Presentation of the ”end product”

The Heterogeneous Technology Alliance HTA Project Idea: Individual cardiovascular EU call:H2020-PHC19,16,24 or 25 Project Idea short description: European Alliance for easy individual cardiovascular risk assessment Short Description: Assessment of cardiovascular risk is nowadays performed on the basis of statistical analysis as proposed by the WHO: a subject is classified as risky/safe according to risk factors such as physical activity, diet, lipid blood content… which are calculated on a worldwide risk basis. This project aims at creating novel cheap tools to assess individual CV risk by: 1) developing easy-to-use unsupervised sensors (self-beaming ultra-sound, PPG, IPG, …) 2) developing easy-to-observe numerical cardiovascular models (distributed windkessel models, arterial stiffening models, cerebral circulation, …) that can be observed by the sensors in 1) 3) and finally by categorizing subjects according to their particular cardiovascular status IP situation and commercial viability: CSEM has a large patent portfolio about the portable physiological sensors Potential Applications / Applications: Cardiovascular risk management, Personalized Health Care, cost reduction in healthcare systems Potential Consortium/Competences needed: Physiological sensors, cardiovascular imaging, cardiovascular modelling, clinical trials Contact:

The Heterogeneous Technology Alliance HTA Advertisement/Presentation of the ”end product” TODAY OUR VISION Blood samples Age Gender Diet Physical activity Tobacco Obesity Worldwide risk model Your most-likely risk ? Your personalized risk